H-Index
70
Scimago Lab
powered by Scopus
Clarivate
Analytics
Formerly the IP & Science
business of Thomson Reuters

Logo




eISSN: 1643-3750

Is (90)Y-DOTATOC treatment for neuroendocrine tumours safe?

Markus Cybulla, Stefan M Weiner, Andreas Otte

Med Sci Monit 2002; 8(4): BR

ID: 420884

Published:


Keywords: Animals, Antineoplastic Agents, Hormonal, Carcinoma, Medullary, Humans, Hypertension, Renal, Kidney Failure, Chronic, neuroendocrine tumors, octreotide, Radiopharmaceuticals, Receptors, Somatostatin, Thyroid Neoplasms, Yttrium Radioisotopes



Back